Abeona Therapeutics Inc (ABEO) — Cash Flow Quality Index
Abeona Therapeutics Inc (ABEO) has a Cash Flow Quality Index of -0.17x as of June 2025. Operating cash flow of $-18.78 Million is below net income of $108.83 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore ABEO operating cash flow to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Abeona Therapeutics Inc Cash Flow Quality Index (1995–2025)
Historical Cash Flow Quality Index for Abeona Therapeutics Inc across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Abeona Therapeutics Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Abeona Therapeutics Inc (1995–2025)
Year-by-year earnings quality comparison for Abeona Therapeutics Inc. For live market cap and the full company financial profile, see Abeona Therapeutics Inc (ABEO) total market value.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -1.07x | $-76.33 Million | $71.18 Million | ▼ -477144.2% |
| 2013 | 0.00x | $1.00K | $4.45 Million | ▼ -100.0% |
| 1995 | 1.93x | $658.00K | $341.00K | — |